期刊文献+

壳聚糖在胰岛素口服给药中的作用 被引量:6

Investigating the role of Chitosan in the oral insulin preparations
下载PDF
导出
摘要 目的:研究壳聚糖在胰岛素口服给药中的作用。方法:以降糖百分数为指标,考察胰岛素溶液、壳聚糖溶液、壳聚糖-胰岛素混合液经正常大鼠口腔给药后对血糖的影响。结果:壳聚糖-胰岛素溶液的降血糖作用与胰岛素溶液相比有显著性差异(P=0.001),而与壳聚糖溶液相比无显著性差异(P=0.069)。结论:壳聚糖具有一定的降血糖作用,并且它的特殊结构还对胰岛素起到了保护和促进吸收的作用,是一种优良的胰岛素口服制剂的载体。 Objective: To investigate the role of Chitosan in the oral insulin preparations. Methods: We investigated the hypoglycemic effect after oral administration of Chitosan, insulin solution, Chitosan insulin mixture to the normal rats by blood glucose changes. Results: Compared with the function of the insulin solution, the Chitosan insulin is markedly different, rnoreover, it has no difference with the Chitosan solution. Conclusion: Chitosan itself has some hypoglycemic effect, and the special structure of the Chitosan can be also served to protect and promote the role of absorption of insulin, it is a good carrier of oral insulin preparations.
出处 《河南大学学报(医学版)》 CAS 2009年第2期118-120,共3页 Journal of Henan University:Medical Science
关键词 胰岛素 壳聚糖 口腔给药 降血糖作用 Insulin Chitosan Oral administration Hypoglyeemic effect
  • 相关文献

参考文献2

  • 1邹良,肖国民,钱林法,刘岐山.胰岛素口服制剂的研究进展[J].东南大学学报(医学版),2003,22(3):203-206. 被引量:2
  • 2Nicolaas G. M. Schipper,Susanne Olsson,Janet A. Hoogstraate,Albertus G. deBoer,Kjell M. V?rum,Per Artursson. Chitosans as Absorption Enhancers for Poorly Absorbable Drugs 2: Mechanism of Absorption Enhancement[J] 1997,Pharmaceutical Research(7):923~929

二级参考文献32

  • 1杨彩哲,张忠兵,胡家露,徐梁,吴道澄,赵伯钦,张学庸.胰岛素毫微囊口服制剂的制备及其对实验性糖尿病的治疗作用[J].第四军医大学学报,1994,15(1):65-66. 被引量:14
  • 2NISHIHATA T, LIVERSIDGE G, HIGUCHI T, et al. Effect of aprotinin on the rectal delivery of insulin[J] .J Phann Pharmacol, 1983,35(9) :616-617.
  • 3AUNGST B J, ROGERS N J. Comparison of the effects of various transmucosal absorption promoters on buccal insulin delivery[ J]. Int J Phann, 1989,53 (3) :227-235.
  • 4HIRAI S, YASHIKI T, MIMA H,et al.Effeet of surfactants on the nasal absorption of insulin in rats[J] .Int J Phalm, 1981,9(2) : 165- 172.
  • 5HIRAI S, YASHIKI T,MIMA H,et al. Mechanisms for the enhancement of the nasal absorpdon of insulin by surfactants [ J]. Int J Phann, 1981,9(2) : 173-184.
  • 6SAFFRAN M,SUDESH G,SAVARIAR C,et al.A new approach to the oral administration of insulin and other peptide drugs[J]. Science, 1987,233(4768) : 1081-1084.
  • 7DAMGE C,MICHEL C,APROHAMIAN M,et al. New approach for oral administration of insulin with polyalkyl cyanoacrylate nanocapsules as drug carrier[J]. Diabetes, 1988,37(2) :246-251.
  • 8DAMGE C, HILLAIRE-BUYS D,PUECH R, et al. Effect of orally administrated insulin nanocapsules in normal and diabetic dogs[J].Diab Nutr Mtab, 1995,8( 1 ) : 3-8.
  • 9DAVIS S. Developing delivery system for peptides and proteins[ J]. Scrip Magazine, 1992,5 (1) : 34-38.
  • 10LOWE P J, TEMPLE C S. Calcitonin and insulin in isobutyl cyanoacrylate nanocapsules: protection against protease and effect in intestinal absorption in rats[J]. J Phann Pharmacol, 1994,46(7) : 547-552.

共引文献1

同被引文献115

引证文献6

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部